Cargando…

Prevalence of testosterone deficiency in HIV-infected men under antiretroviral therapy

BACKGROUND: The prevalence of hypogonadism in HIV-infected patients is still a matter of debate as there is no standardized consensual diagnostic method. In addition, the etiology and endocrine/metabolic implications of hypogonadism in this population remain controversial. This study aims to determi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomes, Ana Rita, Souteiro, Pedro, Silva, Carolina Germana, Sousa-Pinto, Bernardo, Almeida, Francisco, Sarmento, António, Carvalho, Davide, Freitas, Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096002/
https://www.ncbi.nlm.nih.gov/pubmed/27809804
http://dx.doi.org/10.1186/s12879-016-1892-5
_version_ 1782465391534014464
author Gomes, Ana Rita
Souteiro, Pedro
Silva, Carolina Germana
Sousa-Pinto, Bernardo
Almeida, Francisco
Sarmento, António
Carvalho, Davide
Freitas, Paula
author_facet Gomes, Ana Rita
Souteiro, Pedro
Silva, Carolina Germana
Sousa-Pinto, Bernardo
Almeida, Francisco
Sarmento, António
Carvalho, Davide
Freitas, Paula
author_sort Gomes, Ana Rita
collection PubMed
description BACKGROUND: The prevalence of hypogonadism in HIV-infected patients is still a matter of debate as there is no standardized consensual diagnostic method. In addition, the etiology and endocrine/metabolic implications of hypogonadism in this population remain controversial. This study aims to determine the prevalence of testosterone deficiency in a single-site hospital and to evaluate its association with potential risk factors, lipodystrophy, metabolic syndrome, and cardiovascular risk. METHODS: This study analyzed 245 HIV-infected men on combined antiretroviral therapy. Patients with low total testosterone (TT) levels (<2.8 ng/mL) and/or low calculated free testosterone (FT) levels (<6.5 ng/dL) were considered testosterone deficient. According to their LH and FSH levels, patients were classified as having hypogonadotropic or hypergonadotropic dysfunction. Other clinical, anthropometric, and analytic parameters were also collected and analyzed. RESULTS: The prevalence of testosterone deficiency in our population was 29.4 %. Among them, 56.9 % had hypogonadotropic dysfunction and 43.1 % presented with hypergonadotropic dysfunction. Patients with testosterone deficiency were older (p < 0.001), had higher HbA1c levels (p = 0.016) and higher systolic blood pressure (p = 0.007). Patients with lower testosterone levels had higher prevalence of isolated central fat accumulation (p = 0.015) and had higher median cardiovascular risk at 10 years as measured by the Framingham Risk Score (p = 0.004) and 10-Year ASCVD risk (p = 0.002). CONCLUSIONS: The prevalence of testosterone deficiency in this HIV population is high, with hypogonadotropic dysfunction being responsible for the majority of cases. Testosterone deficiency might predispose to, or be involved, in the pathogenesis of HIV-associated lipodystrophy. Patients with low testosterone levels have higher cardiovascular risk, highlighting the importance of early diagnosis of this condition.
format Online
Article
Text
id pubmed-5096002
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50960022016-11-07 Prevalence of testosterone deficiency in HIV-infected men under antiretroviral therapy Gomes, Ana Rita Souteiro, Pedro Silva, Carolina Germana Sousa-Pinto, Bernardo Almeida, Francisco Sarmento, António Carvalho, Davide Freitas, Paula BMC Infect Dis Research Article BACKGROUND: The prevalence of hypogonadism in HIV-infected patients is still a matter of debate as there is no standardized consensual diagnostic method. In addition, the etiology and endocrine/metabolic implications of hypogonadism in this population remain controversial. This study aims to determine the prevalence of testosterone deficiency in a single-site hospital and to evaluate its association with potential risk factors, lipodystrophy, metabolic syndrome, and cardiovascular risk. METHODS: This study analyzed 245 HIV-infected men on combined antiretroviral therapy. Patients with low total testosterone (TT) levels (<2.8 ng/mL) and/or low calculated free testosterone (FT) levels (<6.5 ng/dL) were considered testosterone deficient. According to their LH and FSH levels, patients were classified as having hypogonadotropic or hypergonadotropic dysfunction. Other clinical, anthropometric, and analytic parameters were also collected and analyzed. RESULTS: The prevalence of testosterone deficiency in our population was 29.4 %. Among them, 56.9 % had hypogonadotropic dysfunction and 43.1 % presented with hypergonadotropic dysfunction. Patients with testosterone deficiency were older (p < 0.001), had higher HbA1c levels (p = 0.016) and higher systolic blood pressure (p = 0.007). Patients with lower testosterone levels had higher prevalence of isolated central fat accumulation (p = 0.015) and had higher median cardiovascular risk at 10 years as measured by the Framingham Risk Score (p = 0.004) and 10-Year ASCVD risk (p = 0.002). CONCLUSIONS: The prevalence of testosterone deficiency in this HIV population is high, with hypogonadotropic dysfunction being responsible for the majority of cases. Testosterone deficiency might predispose to, or be involved, in the pathogenesis of HIV-associated lipodystrophy. Patients with low testosterone levels have higher cardiovascular risk, highlighting the importance of early diagnosis of this condition. BioMed Central 2016-11-03 /pmc/articles/PMC5096002/ /pubmed/27809804 http://dx.doi.org/10.1186/s12879-016-1892-5 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Gomes, Ana Rita
Souteiro, Pedro
Silva, Carolina Germana
Sousa-Pinto, Bernardo
Almeida, Francisco
Sarmento, António
Carvalho, Davide
Freitas, Paula
Prevalence of testosterone deficiency in HIV-infected men under antiretroviral therapy
title Prevalence of testosterone deficiency in HIV-infected men under antiretroviral therapy
title_full Prevalence of testosterone deficiency in HIV-infected men under antiretroviral therapy
title_fullStr Prevalence of testosterone deficiency in HIV-infected men under antiretroviral therapy
title_full_unstemmed Prevalence of testosterone deficiency in HIV-infected men under antiretroviral therapy
title_short Prevalence of testosterone deficiency in HIV-infected men under antiretroviral therapy
title_sort prevalence of testosterone deficiency in hiv-infected men under antiretroviral therapy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096002/
https://www.ncbi.nlm.nih.gov/pubmed/27809804
http://dx.doi.org/10.1186/s12879-016-1892-5
work_keys_str_mv AT gomesanarita prevalenceoftestosteronedeficiencyinhivinfectedmenunderantiretroviraltherapy
AT souteiropedro prevalenceoftestosteronedeficiencyinhivinfectedmenunderantiretroviraltherapy
AT silvacarolinagermana prevalenceoftestosteronedeficiencyinhivinfectedmenunderantiretroviraltherapy
AT sousapintobernardo prevalenceoftestosteronedeficiencyinhivinfectedmenunderantiretroviraltherapy
AT almeidafrancisco prevalenceoftestosteronedeficiencyinhivinfectedmenunderantiretroviraltherapy
AT sarmentoantonio prevalenceoftestosteronedeficiencyinhivinfectedmenunderantiretroviraltherapy
AT carvalhodavide prevalenceoftestosteronedeficiencyinhivinfectedmenunderantiretroviraltherapy
AT freitaspaula prevalenceoftestosteronedeficiencyinhivinfectedmenunderantiretroviraltherapy